1Assistant Professor, SGT Medical College and Research Institute, Gurugram, Haryana, India
2Professor, SGT Medical College and Research Institute, Gurugram, Haryana, India
3Junior Resident, SGT Medical College and Research Institute, Gurugram, Haryana, India
*Corresponding Author E-mail: mrudulkyada@ymail.com
Online Published on 08 October, 2025.
Periarthritis of the shoulder, characterised by pain and stiffness, poses challenges in management. While corticosteroid injections are commonly used, platelet-rich plasma (PRP) has emerged as a potential alternative due to its regenerative properties. This study aims to compare the efficacy of intra-articular injections of triamcinolone versus PRP in treating periarthritis of the shoulder.
A parallel-group, prospective, randomised clinical trial was conducted. Fifty patients diagnosed with periarthritis were randomised into two groups: Triamcinolone (n=25) and PRP (n=25). Pain and functional outcomes were assessed using Visual Analog Scale (VAS) and Disabilities of Arm, Shoulder, and Hand (DASH) scores at baseline 1, 3 and 6 Months post-injection. Statistical analyses were performed to compare outcomes between the two groups.
At baseline, there were no significant differences between groups in age, sex distribution, side involvement, or symptom duration. Both groups showed improvement in VAS and DASH scores at 3 months, with PRP demonstrating superior outcomes at 6 months . The PRP group exhibited significantly lower VAS scores and better functional recovery compared to the Triamcinolone group at 6 months (P<0.05).
Intra-articular injections of PRP offer superior long-term benefits compared to triamcinolone in managing periarthritis of the shoulder. While both treatments improve pain and functional outcomes initially, PRP demonstrates prolonged efficacy, highlighting its potential as a promising alternative in periarthritis management.
Periarthritis, Triamcinolone, PRP, VAS Score, DASH Score
